Skip to nav Skip to content


April 25, 2018


Congress Seeks to Advance ID and Opioid Efforts

The Senate Health, Education, Labor and Pensions (HELP) Committee and House Energy and Commerce Committee are voting on new legislation this week to address the opioid epidemic.  Both committees will consider bills that include recommendations from the IDSA/HIVMA/PIDS policy brief released last month, including: expanded surveillance of infectious diseases related to substance use disorder, health care provider training on the  intersection between infectious diseases and the opioid epidemic, increased flexibility to use telehealth to provide care to patients with substance use disorders and related infectious diseases, and an increased limit of the number of patients who can be prescribed medication assistedtreatment (MAT).  

Our societies are working closely with Congress to advance and improve the legislation, including advocating for greater emphasis on coordinated treatment of infectious diseases and substance use disorders and the inclusion of ID and HIV physicians in a new loan repayment opportunity.  Following action by the committees, the bills will be considered by their respective chambers. 

This website uses cookies

We use cookies to ensure that we give you the best experience on our website. Cookies facilitate the functioning of this site including a member login and personalized experience. Cookies are also used to generate analytics to improve this site as well as enable social media functionality.